It is nondialysable, and studies in patients with moderate chronic kidney disease (GFR <50 ml/min/1.73 m 2) demonstrated a reduced rate of fenofibrate excretion and accumulation of the drug with ...

Results: The double-drug regimen given for 12 months to four different groups, according to the different combined dosages of simvastatin and fenofibrate, resulted in a reduction in total ...